BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26129688)

  • 1. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
    Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
    Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
    Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
    Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.
    Rauhala HE; Jalava SE; Isotalo J; Bracken H; Lehmusvaara S; Tammela TL; Oja H; Visakorpi T
    Int J Cancer; 2010 Sep; 127(6):1363-72. PubMed ID: 20073067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
    Noonan EJ; Place RF; Basak S; Pookot D; Li LC
    Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency.
    Jin J; Guo Y; Dong X; Liu J; He Y
    Radiother Oncol; 2020 Sep; 150():104-113. PubMed ID: 32580002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas.
    Kober P; Mossakowska BJ; Rusetska N; Baluszek S; Grecka E; Konopiński R; Matyja E; Oziębło A; Mandat T; Bujko M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets.
    Choi KH; Shin CH; Lee WJ; Ji H; Kim HH
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer.
    Nakamura Y; Felizola SJ; Kurotaki Y; Fujishima F; McNamara KM; Suzuki T; Arai Y; Sasano H
    Prostate; 2013 May; 73(6):590-5. PubMed ID: 23060014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
    Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
    Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma.
    Chen J; Feilotter HE; Paré GC; Zhang X; Pemberton JG; Garady C; Lai D; Yang X; Tron VA
    Am J Pathol; 2010 May; 176(5):2520-9. PubMed ID: 20304954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
    Zhang Z; Shao L; Wang Y; Luo X
    Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1.
    Li Z; Wang H; Wang Z; Cai H
    Tumour Biol; 2016 May; 37(5):6457-63. PubMed ID: 26631043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
    Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
    John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
    Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.